BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9369434)

  • 1. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia.
    Kempski HM; Chessells JM; Reeves BR
    Leukemia; 1997 Nov; 11(11):1973-7. PubMed ID: 9369434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukaemia and transient leukaemia in Down syndrome.
    Iselius L; Jacobs P; Morton N
    Hum Genet; 1990 Oct; 85(5):477-85. PubMed ID: 2146208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome clues to acute leukemia in Down's syndrome.
    Hecht F; Hecht BK; Morgan R; Sandberg AA; Link MP
    Cancer Genet Cytogenet; 1986 Mar; 21(2):93-8. PubMed ID: 2936445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
    Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
    Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic studies in children with Down syndrome and acute leukemia.
    Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
    Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
    Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
    Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired chromosome rearrangements, including fine interstitial deletions, in a patient with Down syndrome and monoblastic leukemia.
    Misawa S; Testa JR; Strauss LC; Leavitt RD; Civin CI
    Pediatrics; 1984 Dec; 74(6):1029-33. PubMed ID: 6239138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and molecular analysis of nondisjunction in 18 cases of trisomy 21 and leukemia.
    Lorber BJ; Freeman SB; Hassold T; Ragab AH; Vega RA; Cockwell AE; Jacobs PA; Radford M; Doyle J; Dubé ID
    Genes Chromosomes Cancer; 1992 Apr; 4(3):222-7. PubMed ID: 1382563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia.
    Rogan PK; Close P; Blouin JL; Seip JR; Gannutz L; Ladda RL; Antonarakis SE
    Am J Med Genet; 1995 Nov; 59(2):174-81. PubMed ID: 8588582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
    Dewald GW; Diez-Martin JL; Steffen SL; Jenkins RB; Stupca PJ; Burgert EO
    Am J Med Genet Suppl; 1990; 7():247-50. PubMed ID: 2149957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, cytogenetic, and molecular characterization of a girl with some clinical features of Down syndrome resulting from a pure partial trisomy 21q22.11-qter due to a de novo intrachromosomal duplication.
    Vaglio A; Milunsky A; Quadrelli A; Huang XL; Maher T; Mechoso B; Martínez S; Pagano S; Bellini S; Costabel M; Quadrelli R
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):57-65. PubMed ID: 20143912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 7 abnormalities in children with Down syndrome and preleukemia.
    Bunin N; Nowell PC; Belasco J; Shah N; Willoughby M; Farber PA; Lange B
    Cancer Genet Cytogenet; 1991 Jul; 54(1):119-26. PubMed ID: 1829646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
    Laurent AP; Kotecha RS; Malinge S
    Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome.
    Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R
    Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningioma in Down Syndrome.
    Yamamoto T; Shinojima N; Todaka T; Nishikawa S; Yano S; Kuratsu J
    World Neurosurg; 2015 Sep; 84(3):866.e1-6. PubMed ID: 25862935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief review of cryptic duplications of 21q as an emerging cause of Down syndrome: practical considerations for accurate detection.
    Garcia-Heras J; Rao PN
    Clin Genet; 1999 Mar; 55(3):207-11. PubMed ID: 10334476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of congenital chromosome abnormalities and malignant diseases].
    Erzsébet B; Andrea N; Róbert S; Eva O
    Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Down syndrome phenotype with severe developmental delay, hypertonia, and seizures in a child with translocation trisomy 21.
    Keppler-Noreuil KM; Welch JL; Major HJ; Qiau Q; Jordan DK; Patil SR
    Dev Med Child Neurol; 2002 Jan; 44(1):64-7. PubMed ID: 11811653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of a fetus affected with Down syndrome and deletion 1p36 syndrome by fluorescence in situ hybridization and spectral karyotyping.
    Hsieh LJ; Hsieh TC; Yeh GP; Lin MI; Chen M; Wang BB
    Fetal Diagn Ther; 2004; 19(4):356-60. PubMed ID: 15192296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.